Richard M. Murray is the Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and Bioengineering at the California Institute of Technology (Caltech). He holds a B.S. from Caltech (1985), M.S. from UC Berkeley (1988), and Ph.D. from UC Berkeley (1990). He has served in academic roles from Assistant Professor (1991–1997) to his current endowed professorship. He chaired the Engineering and Applied Science division (2000–2005) and Biology and Biological Engineering (2020–2024). His research focuses on feedback control in biological and autonomous systems, synthetic cells, and networked control systems. Collaborators include experts in robotics, synthetic biology, and systems biology. Key awards include the IEEE Control Systems Award and election to the National Academy of Engineering. His educational contributions span courses on control systems, robotics, and bioengineering. Current research projects include the Developer Cell initiative (Sloan Foundation), layered testing for autonomous systems (AFOSR), and microbiome-based environmental solutions (CHARMME, ARO). He advises numerous graduate students and postdocs, with notable alumni in academia and industry. Labs include facilities in Keck and Steele laboratories at Caltech. His work bridges control theory, synthetic biology, and autonomous systems to address societal challenges like environmental monitoring and safe autonomy.
Gail E. Kaiser is a Professor of Computer Science and the Director of the Programming Systems Laboratory (PSL) in the Computer Science Department at Columbia University. She has been with Columbia University since 1985, becoming a full Professor in 1998. Prof. Kaiser's research spans software engineering, program analysis, software testing, and software security, with recent focus on addressing challenges in AI/ML systems testing and security. Prof. Kaiser received her PhD in Computer Science from Carnegie Mellon University in 1985 and her ScB in Computer Science and Engineering from MIT in 1979. Her dissertation at CMU was titled "Semantics for Structure Editing Environments" under advisor Nico Habermann, and at MIT she completed "Automatic Extension of an Augmented Transition Network Grammar for Morse Code Conversations" under advisor Al Vezza. Prof. Kaiser's research interests primarily focus on software engineering following a systems building approach, with recent emphasis on static and dynamic program analysis techniques to improve software reliability and security. Since 2005, she has investigated testing "non-testable" programs, particularly in machine learning, data mining, and scientific computing applications where traditional testing oracles are insufficient. She has developed novel techniques and tools for detecting bugs and verifying repairs in complex systems. Concurrently, she has worked on collaboration environments for computational scientists, creating knowledge sharing and domain-aware environments to support scientific workflows. Prof. Kaiser's recent publications demonstrate a strong focus on the intersection of software engineering and artificial intelligence. Her work addresses critical challenges in testing AI systems, code understanding through deep learning, vulnerability detection, and educational tools for computational thinking. There's a clear evolution from traditional software engineering topics toward AI/ML applications, with particular emphasis on metamorphic testing for non-testable systems, code similarity analysis, and educational applications. Prof. Kaiser has received numerous prestigious awards throughout her career: Distinguished Journal Award (10 Years) from 18th IEEE International Conference on Software Testing, Verification and Validation (ICST), April 2025 Best Research Paper Award at 24th IEEE International Conference on Source Code Analysis & Manipulation (SCAM), October 2024 Distinguished Reviewer Awards for ASE 2024 and FSE 2024 ACM SIGSOFT Distinguished Paper Award for "CONCORD: Clone-aware Contrastive Learning for Source Code", July 2023 Best Student Paper Award at ICCE 2021 Multiple ACM SIGSOFT Distinguished Paper Awards dating back to 2014 Presidential Young Investigator in Software Engineering and Software Systems from NSF (1988-1993) Prof. Kaiser has chaired Columbia's doctoral program since 1997 and served on editorial boards including IEEE Internet Computing and as a founding associate editor of ACM Transactions on Software Engineering and Methodology. Her lab has been continuously funded by major agencies including NSF, NIH, DARPA, ONR, NASA, and numerous companies. Current grants include significant NSF funding for secure containers architecture, learning semantics of code for software assurance, and finding semantic security bugs. As Director of the Programming Systems Laboratory (PSL), Prof. Kaiser leads research in software systems, program analysis, and software testing. The lab has developed numerous tools and techniques for software reliability and security, with recent focus on challenges in AI/ML systems. Her work bridges theoretical foundations with practical applications, often resulting in deployable tools that address real-world software engineering challenges.
Mikael Thollesson is a Senior Lecturer at Uppsala University, affiliated with the Department of Organismal Biology; Systematic Biology and Klubban’s Biological Station. His research focuses on evolutionary biology, phylogenetics, taxonomy, and molecular biology, particularly in marine and freshwater sponges (Porifera), bacterial pathogens, and computational methods in evolutionary analysis. Evolutionary Biology Marine Biology Taxonomy His recent publications highlight trends in sponge biodiversity, phylogeography, bacterial horizontal gene transfer, and mitochondrial gene evolution. Key articles include studies on Swedish demosponge faunas, Silene sect. Arenosae systematics, and computational tools like SPRIT for detecting gene transfers. No explicit awards or grants are mentioned.
Dr. Mo Adda is a Principal Lecturer at the University of Portsmouth's School of Computing, part of the Faculty of Technology. He holds a PhD in Distributed Systems and Parallel Processing from the University of Surrey. His research focuses on network security, distributed systems, wireless networks, and cybercrime prevention. He leads projects in the Centre for Cybercrime and Economic Crime, exploring fault management in networks, blockchain applications, and IoT forensics. With 16 supervised theses, he advises on topics like energy-efficient cloud systems and machine learning for environmental modeling. His work bridges academia and industry, addressing challenges in software-defined networks, traffic control, and secure data sharing in social networks. Education: PhD in Distributed Systems (University of Surrey) Affiliations: Centre of Excellence in Defence, Risk & Resilience; Portsmouth Centre for Advanced Materials and Manufacturing Research Interests Dr. Adda's research spans: Network security and fault detection mechanisms Blockchain applications in IoT and forensics Energy-efficient cloud data center optimization Machine learning for climate modeling Self-organizing network protocols Grants & Collaborations His projects include collaborations with industry partners on secure data leakage detection in cloud systems and resilient wireless protocols for harsh environments. He has pioneered fault classification systems using clustering algorithms and fuzzy logic. Labs & Teams He contributes to the Centre for Cybercrime and Economic Crime, focusing on digital forensics and network intrusion analysis. His team develops frameworks for privacy management in social networks and proactive routing in software-defined networks.
David Erickson is the SC Thomas Sze Director and Sibley College Professor at Cornell University's Sibley School of Mechanical and Aerospace Engineering. He also holds a joint professorship in the Division of Nutritional Sciences. His research focuses on global health technologies, medical diagnostics, microfluidics, photonics, nanotechnology, and energy systems. He previously served as Associate Dean of Engineering for Research and Graduate Programs. Erickson leads the NIH-funded PORTENT Center for Point-of-Care Technologies in Global Health and has co-founded companies like Dimensional Energy and VitaScan to commercialize diagnostic and energy technologies. Education: B.Sc., Mechanical Engineering, University of Alberta (1999) M.A.Sc., Mechanical Engineering, University of Toronto (2001) Ph.D., Mechanical Engineering, University of Toronto (2004) Postdoctoral Scholar, Electrical Engineering, California Institute of Technology (2005) Research Interests: Erickson’s work spans global health diagnostics , nanobio applications , and clean energy innovation . He develops portable medical devices for low-resource settings, including smartphone-integrated diagnostic tools for malaria, iron deficiency, and cancer. His lab also pioneers photothermal reactors for CO2 conversion into sustainable fuels. Key areas include: Point-of-care testing for infectious diseases and nutritional deficiencies Nanofluidic and optofluidic technologies for biomolecular analysis Solar-driven energy systems for carbon-neutral fuels Awards: Presidential Early Career Award for Scientists and Engineers (2011) Fellowships from the Optical Society, ASME, and Canadian Academy of Engineering Carbon X-Prize Finalist (2019) for Dimensional Energy’s CO2-to-fuel technology Grants & Industry Collaboration: Erickson’s research is funded by NIH, NSF, ARPA-E, DOE, and USAID. His lab’s innovations have spun off start-ups addressing global health and energy challenges. Notable projects include: - Portable cancer diagnostics in sub-Saharan Africa using mobile phone-based systems - Solar-powered CO2 conversion reactors tested in Wyoming and Arizona Labs & Teams: The Erickson Lab collaborates with the Cornell Atkinson Center for Sustainability and the McGovern Center for Entrepreneurship. Key initiatives include the PORTENT Center and the Dimensional Energy CO2-to-fuel project.
Dr. Vakil Takhaveev is a Lecturer at ETH Zurich's Department of Health Sciences and Technology, within the Institute of Food, Nutrition and Health. His research focuses on DNA damage mechanisms, aging, cancer, and neurodegeneration, with particular emphasis on developing novel DNA-damage-sequencing methods like click-code-seq and TRABI-Seq . He investigates anticancer drug action (e.g., trabectedin), aging clocks using DNA oxidation profiling, and stress-induced carcinogenesis. His work integrates multi-omics approaches and advanced sequencing techniques. Research Directions: Novel DNA-Damage-Sequencing Methods: Developed click-code-seq and TRABI-Seq for genomic mapping of DNA lesions and repair dynamics. Anticancer Drug Action: Explored mechanisms of trabectedin and other chemotherapeutics, linking DNA repair vulnerabilities to therapy resistance. Aging Clocks: Created DNA oxidation-based biomarkers for biological aging using genome-wide profiling in human and mouse models. Stress-Induced Pathologies: Studies metabolic and DNA damage links to early tumorigenesis and neurodegeneration. Awards & Recognition: 2025 Public Award Winner in PIs of Tomorrow competition 2024 ETH Zurich Career Seed Award Best presentation awards (Swiss Chemical Society, American Chemical Society) Grants & Collaborations: Impetus grants for aging clock development Swiss Chemical Society and American Chemical Society fellowships Labs & Teams: Leads research on DNA damage and aging mechanisms at ETH Zurich, collaborating with international groups in oncology and toxicology.
John D Brennan is a Professor in the Department of Chemistry & Chemical Biology at McMaster University. He is affiliated with the Biointerfaces Institute and focuses on developing innovative biosensing technologies and functional nucleic acid-based assays. His research integrates materials science, biochemistry, and analytical chemistry to create practical diagnostic tools for healthcare applications. Key research areas include the design of DNA aptamers and DNAzymes for detecting biomarkers (e.g., eosinophil peroxidase, SARS-CoV-2 spike proteins), development of paper-based diagnostic platforms, and optimization of sol-gel materials for enzyme entrapment. His work emphasizes high-throughput screening, point-of-care testing, and CRISPR-based biosensing systems. Notable contributions include a rapid sputum-based assay for asthma biomarkers and a universal DNA aptamer for SARS-CoV-2 variants. His lab also explores functional nucleic acid circuits and their integration into scalable diagnostic devices. Brennan’s teaching includes advanced courses in analytical chemistry and biochemical assay development. His work has been featured in journals like *Angewandte Chemie*, *Analytical Chemistry*, and *ChemBioChem*, with a focus on translating fundamental research into practical clinical applications.
Harri Lähdesmäki is an Associate Professor (tenured) at the Department of Computer Science, Aalto University, where he leads the Computational Systems Biology research group. His work focuses on probabilistic machine learning and deep generative models with applications in biomedicine and molecular biology. Key Research Interests: Probabilistic machine learning, deep generative models, computational biology, bioinformatics, longitudinal data modeling Contact: harri.lahdesmaki@aalto.fi | Konemiehentie 2, 02150 Espoo, Finland His recent publications highlight advancements in: Gaussian process priors for scalable deep generative models Single-cell analysis of immune repertoires in leukemia and diabetes Probabilistic deconvolution methods for RNA-seq data Epigenetic analysis using hidden Markov and mixed models Transformer-based survival prediction and missing data handling Harri’s work integrates mechanistic modeling with Bayesian inference, particularly applied to immunology, cancer biology, and early disease prediction.
Assoc Prof Ng Teng Yong is an Associate Professor at the School of Mechanical & Aerospace Engineering (NTU), specializing in numerical modeling and simulation. With a background as Research Manager at A*STAR Institute of High Performance Computing, his work spans materials science, nanotechnology, and aerospace engineering. Current focus on graphene-based desalination membranes Expertise in molecular dynamics simulations Investigates nanoscale fluid mechanics and structural dynamics Recent publications highlight advancements in energy-efficient electrodialysis, smart robotics, and nonlinear vibration analysis. His interdisciplinary approach integrates computational methods with experimental validation in additive manufacturing and soft material mechanics.
Lauren Andrews serves as Associate Professor and Marvin and Eva Schlanger Faculty Fellow in the Department of Chemical Engineering at the University of Massachusetts Amherst. Her research integrates synthetic biology and genetic engineering to develop programmable cellular systems for biotechnological applications. Education: Postdoctoral Training: Massachusetts Institute of Technology (Biological Engineering and Broad Institute of MIT and Harvard) PhD: University of Colorado Boulder, Chemical Engineering (2012) MS: University of Colorado Boulder, Chemical Engineering (2009) BS: Cornell University, Chemical Engineering (2006) Dr. Andrews' research focuses on establishing genetic design rules for reprogramming cellular regulation and metabolism. Her lab pioneers synthetic gene networks, genetically-encoded biosensors, and high-throughput methodologies for optimizing genetic designs in both model and non-model bacteria. This work enables precise control of cellular sensing, memory, and environmental responses through multiplexed DNA assembly and next-generation sequencing. Analysis of her 15 most recent publications reveals dominant themes in bacterial biosensor development (particularly for bioremediation), quorum sensing engineering, and programmable genetic circuits for probiotic applications. Her research consistently bridges fundamental genetic circuit design with practical implementations in bacterial consortia and non-model organisms. Scientific Awards: Marvin and Eva Schlanger Faculty Fellowship NSF CAREER Award (2020) for "Programmable synthetic microbial consortia for complex multicellular functions" Her grant portfolio demonstrates significant funding for collaborative research in bacterial communication systems and model-guided design of synthetic ecosystems. The Andrews Lab maintains active partnerships with the MIT-Broad Foundry and Cold Spring Harbor Laboratory, where she co-founded the Synthetic Biology Summer Course. Current projects focus on CRISPR-based regulation in non-model bacteria and algorithmic programming of sequential logic in probiotic strains. The Andrews Lab operates within the Life Science Laboratories at UMass Amherst, utilizing advanced facilities for genetic prototyping and high-throughput screening. Her team develops multiplexed tools for exploring genetic design spaces, with particular emphasis on soil bacteria and Gram-positive pathogens for environmental and therapeutic applications.
Matthew Lakin is an Associate Professor with tenure in the Department of Computer Science at the University of New Mexico, with a courtesy appointment in the Department of Chemical & Biological Engineering. He is affiliated with the UNM Center for Biomedical Engineering and the School of Engineering, and collaborates extensively with the UNM Health Sciences Center and external institutions. Education: Ph.D., Computer Science, University of Cambridge, 2010 M.A. (Cantab), University of Cambridge, 2009 B.A. (Hons), Computer Science, University of Cambridge, 2005 Dr. Lakin's research focuses on molecular computing, DNA nanotechnology, synthetic biology, and formal verification of biomolecular circuits. He develops computational models and experimental systems for programmable biological devices, especially using heterochiral DNA to enhance stability in living cells. His work spans software tools for biodesign and experimental validation in mammalian systems, with applications in nanomedicine and biosensing. The recent publications highlight a strong trend in engineering robust, intelligent biomolecular systems. His work integrates machine learning concepts into chemical reaction networks, advances geometric modeling of DNA systems, and pioneers L-DNA-based circuits for intracellular applications. The research spans theoretical foundations, software tools, and wet-lab experimentation, emphasizing interdisciplinary innovation. Scientific Awards: Presidential Early Career Award for Scientists and Engineers (PECASE), 2025 NSF CAREER Award, 2021 UNM School of Engineering Junior Faculty Research Excellence Award, 2021 Multiple student awards under his mentorship, including the Outstanding Graduate Student Award and DNA28 Best Student Presentation recognition Dr. Lakin has advised numerous graduate and undergraduate students, including Ph.D. graduates in Biomedical Engineering and Computer Science. He leads major funded projects such as the NSF CAREER grant on heterochiral molecular computing, an EPSCoR Research Fellowship, and a $3M NSF grant on heavy metal biosensing in collaboration with Native American communities. He is also PI on multiple NSF grants related to synthetic cells and nucleic acid technologies. He directs the Lakin Lab for Programmable Biology, which operates within the Department of Computer Science and collaborates with Chemical & Biological Engineering and the Center for Biomedical Engineering. The lab emphasizes both computational modeling and experimental molecular biology, and runs an NSF-funded biotechnology summer camp in partnership with ¡Explora! science museum to strengthen STEM education in New Mexico.
Asbjørn Moltke is a Postdoctoral Researcher at the Department of Electrical and Photonics Engineering at the Technical University of Denmark (DTU), working within the Fiber Sensors & Supercontinuum research group. His research is centered on advanced photonic technologies, including supercontinuum generation, ultrafast lasers, and nonlinear optical phenomena, with applications in renewable energy and biosensing. His research interests span nonlinear optics , fiber photonics , UV light generation , and laser-based material processing . He applies these technologies to areas such as solar cell fabrication , optical sensing , and metasurface engineering . His work contributes to UN Sustainable Development Goals related to clean energy and responsible innovation. The recent publications highlight a strong trend in developing high-power, low-noise UV and visible supercontinuum sources through pump modulation techniques, as well as their application in solar cell processing and biomolecular detection . These works reflect a multidisciplinary approach combining theoretical modeling, numerical simulation, and experimental validation in advanced photonic systems. No scientific awards were mentioned in the provided text. Asbjørn Moltke has been involved in significant research projects and has served as a supervisor in a PhD project focused on UV supercontinuum sources and metasurfaces. He has presented his work at international conferences, demonstrating active engagement in the scientific community. While no specific grants are listed, his participation in funded PhD projects indicates involvement in competitively supported research. He is affiliated with the Fiber Sensors & Supercontinuum group at DTU, a leading team in nonlinear fiber optics and advanced light source development. This team focuses on pushing the boundaries of supercontinuum technology for industrial and biomedical applications.
Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .
Dr. Thomas A. Hughes is an Associate Professor of Cancer Biology at the University of Leeds and Professor of Biosciences at York St John University. As a Group Leader at the Leeds Institute of Medical Research, he focuses on gene regulation, tumour microenvironment, and nanomedicine approaches to improve cancer outcomes. Specializes in breast cancer, colorectal cancer, and rare diseases Develops therapeutic strategies using microRNAs and biomarkers Collaborates with clinicians, engineers, and chemists for translational research His research integrates molecular pathology with clinical data through partnerships with Leeds NHS Trusts, aiming to identify novel biomarkers and targets for therapy. Recent work emphasizes cholesterol metabolism, oxysterol signaling, and nanomedicine-based drug delivery systems. Key contributions include: Over 80 peer-reviewed publications in cancer biology and molecular therapeutics Leadership in MSc programs in Molecular Medicine and Cancer Biology and Therapy Extensive experience in grant review, editorial work, and doctoral supervision Scientific awards include Fellowship of the Higher Education Academy. His lab has mentored 26 doctoral students and numerous alumni in academia, clinical practice, and industry.
Anthony Lucci, M.D. is a Professor in the Department of Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center with a dual appointment in the Department of Surgical Oncology, Division of Surgery. He serves as Principal Investigator of the Lucci Laboratory, focusing on innovative cancer research approaches. Dr. Lucci's research interests center on liquid biopsy-based approaches for cancer detection and monitoring. His laboratory investigates circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), proteomics, and exosomes to develop comprehensive disease snapshots for individual cancer patients. The lab has collected serial blood draws from over 830 breast cancer patients and more than 800 melanoma patients. Specializes in triple-negative and inflammatory breast cancer research Investigates Stage II-IV cutaneous and uveal melanoma Develops methods to predict cancer recurrence Identifies novel therapeutic targets through liquid biopsies Studies mechanisms of treatment resistance The Lucci Laboratory has made significant contributions to understanding how CTCs and ctDNA can predict disease progression better than many conventional clinical parameters. Their research has shown that protein expression in CTCs (like HER2) can differ from primary tumors, opening new therapeutic possibilities for patients.
